The findings concur with clinical practice recommendations that contraindicate the use of GLP-1 RAs in such groups due to safety concerns.[22] More recent meta-analyses demonstrate that GLP-1 RAs have protective renal effects in diabetes patients, and contraindications should therefore be assessed individually.[23]. Here, GCG is linked to diabetes mellitus.